These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 38834991)
1. Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease. Hosseini SA; Alipour M; Sarvandian S; Haghighat N; Bazyar H; Aghakhani L BMC Endocr Disord; 2024 Jun; 24(1):79. PubMed ID: 38834991 [TBL] [Abstract][Full Text] [Related]
2. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study. Zakerkish M; Hoseinian A; Alipour M; Payami SP BMC Endocr Disord; 2023 May; 23(1):122. PubMed ID: 37246210 [TBL] [Abstract][Full Text] [Related]
3. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Li H; Zhang Y; Luo H; Lin R Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325 [TBL] [Abstract][Full Text] [Related]
4. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716 [TBL] [Abstract][Full Text] [Related]
5. Comparison of novel and traditional anthropometric indices in Eastern-China adults: which is the best indicator of the metabolically obese normal weight phenotype? Chen Y; Wang C; Sun Q; Ye Q; Zhou H; Qin Z; Qi S; Wang W; Hong X BMC Public Health; 2024 Aug; 24(1):2192. PubMed ID: 39138449 [TBL] [Abstract][Full Text] [Related]
6. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. Lin IT; Lee MY; Wang CW; Wu DW; Chen SC Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329 [TBL] [Abstract][Full Text] [Related]
7. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study. Gui J; Li Y; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L Front Public Health; 2023; 11():1073824. PubMed ID: 36875382 [TBL] [Abstract][Full Text] [Related]
8. Anthropometric parameter that best predict metabolic syndrome in South west Nigeria. Adejumo EN; Adejumo AO; Azenabor A; Ekun AO; Enitan SS; Adebola OK; Ogundahunsi OA Diabetes Metab Syndr; 2019; 13(1):48-54. PubMed ID: 30641748 [TBL] [Abstract][Full Text] [Related]
9. Cut-off points for anthropometric indices to screen for hypertension among Iranian adults of the Bandare-Kong cohort: a cross-sectional study. Azarbad A; Aghnia T; Gharibzadeh A; Rafati S; Hashemi SM; Zarei H; Kheirandish M BMC Public Health; 2022 Nov; 22(1):2064. PubMed ID: 36369024 [TBL] [Abstract][Full Text] [Related]
10. Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese. Zhang X; Wang Y; Li Y; Gui J; Mei Y; Yang X; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Li J; Liu M; Hua Y; Zhang L Sci Rep; 2024 May; 14(1):10901. PubMed ID: 38740846 [TBL] [Abstract][Full Text] [Related]
11. [Screening value and correlation of body measurement indices for metabolic syndrome in the population undergoing physical examinations in Chengdu during 2018-2020]. Xue J; Ni G; Liu Y; Wan Z; Sun P Wei Sheng Yan Jiu; 2024 Jan; 53(1):21-29. PubMed ID: 38443169 [TBL] [Abstract][Full Text] [Related]
12. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome. Uysal E; Tammo O; Soylemez E; Incebıyık M; Filiz D; Alci M BMC Endocr Disord; 2024 Aug; 24(1):160. PubMed ID: 39198818 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of anthropometric indices of obesity as correlates and potential predictors of risk for hypertension and prehypertension in a population in Nigeria. Ononamadu CJ; Ezekwesili CN; Onyeukwu OF; Umeoguaju UF; Ezeigwe OC; Ihegboro GO Cardiovasc J Afr; 2017 Mar/Apr 23; 28(2):92-99. PubMed ID: 27701484 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency. Qing L; Wei R; Chan L; Xiaoya Z; Xin X J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232 [TBL] [Abstract][Full Text] [Related]
15. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Xie F; Pei Y; Zhou Q; Cao D; Wang Y Lipids Health Dis; 2021 Oct; 20(1):132. PubMed ID: 34629056 [TBL] [Abstract][Full Text] [Related]
16. Body roundness index is a superior indicator to associate with the cardio-metabolic risk: evidence from a cross-sectional study with 17,000 Eastern-China adults. Xu J; Zhang L; Wu Q; Zhou Y; Jin Z; Li Z; Zhu Y BMC Cardiovasc Disord; 2021 Feb; 21(1):97. PubMed ID: 33593274 [TBL] [Abstract][Full Text] [Related]
17. Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study. Wang H; Liu A; Zhao T; Gong X; Pang T; Zhou Y; Xiao Y; Yan Y; Fan C; Teng W; Lai Y; Shan Z BMJ Open; 2017 Sep; 7(9):e016062. PubMed ID: 28928179 [TBL] [Abstract][Full Text] [Related]
18. Association between anthropometric indices and hyperuricemia: a nationwide study in China. Chen D; Lu C; Chen K; Liu T; Li Y; Shan Z; Teng W; Clin Rheumatol; 2024 Mar; 43(3):907-920. PubMed ID: 38315297 [TBL] [Abstract][Full Text] [Related]
20. Role of anthropometric indices as a screening tool for predicting metabolic syndrome among apparently healthy individuals of Karachi, Pakistan. Adil SO; Musa KI; Uddin F; Shafique K; Khan A; Islam MA Front Endocrinol (Lausanne); 2023; 14():1223424. PubMed ID: 37876536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]